BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11134758)

  • 1. Clonality detection in apheresis products from multiple myeloma and non-Hodgkin lymphoma patients.
    Araújo MJ; Carvalhais A; Campos A; Vaz CP; Campilho F; Pimentel P; Barbosa IL
    Transplant Proc; 2000 Dec; 32(8):2676. PubMed ID: 11134758
    [No Abstract]   [Full Text] [Related]  

  • 2. G-CSF plus plerixafor (Mozobil) to mobilize hematopoietic stem cells in patients with thrombocytopenia or leukopenia prior to auto-SCT.
    Micallef IN; Jacobsen ED; Shaughnessy P; Gandhi PJ; Calandra G; van Rhee F; Uberti J
    Bone Marrow Transplant; 2013 Feb; 48(2):303-4. PubMed ID: 22773123
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene scanning of VDJH-amplified segments is a clinically relevant technique to detect contaminating tumor cells in the apheresis products of multiple myeloma patients undergoing autologous peripheral blood stem cell transplantation.
    López-Pérez R; García-Sanz R; González D; Balanzategui A; Chillón MC; Alaejos I; Mateos MV; Caballero MD; Corral M; Orfão A; González M; San Miguel JF
    Bone Marrow Transplant; 2001 Oct; 28(7):665-72. PubMed ID: 11704789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing the timing of chemotherapy for mobilizing autologous blood hematopoietic progenitor cells.
    Hicks ML; Lonial S; Langston A; Flowers C; Roback JD; Smith KJ; Mossavi Sai S; Teagarden D; Hamilton ES; Waller EK; Kaufman J
    Transfusion; 2007 Apr; 47(4):629-35. PubMed ID: 17381621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Real-time polymerase chain reaction in multiple myeloma: quantitative analysis of tumor contamination of stem cell harvests.
    Ladetto M; Omedè P; Sametti S; Donovan JW; Astolfi M; Drandi D; Volpato F; Giaccone L; Giaretta F; Palumbo A; Bruno B; Pileri A; Gribben JG; Boccadoro M
    Exp Hematol; 2002 Jun; 30(6):529-36. PubMed ID: 12063019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward a more rational policy for autologous hematopoietic stem cell mobilization.
    Devine SM
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1468-70. PubMed ID: 22892553
    [No Abstract]   [Full Text] [Related]  

  • 8. Hematopoietic progenitor cell mobilization using low-dose cyclophosphamide and granulocyte colony-stimulating factor for multiple myeloma.
    Shimura Y; Kuroda J; Uchiyama H; Kawata-Iida E; Tsutsumi Y; Nagoshi H; Mizutani S; Yamamoto-Sugitani M; Matsumoto Y; Kobayashi T; Horiike S; Shimazaki C; Kaneko H; Kobayashi Y; Taniwaki M
    J Clin Apher; 2013 Oct; 28(5):368-73. PubMed ID: 23804501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood stem cell collection: factors influencing the recovery of granulocyte-macrophage colony forming cells.
    Imrie K; Stewart AK; Crump RM; Prince HM; Trip K; Keating A
    Cell Transplant; 1996; 5(3):379-83. PubMed ID: 8727006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The kinetics of hematopoietic niche cytokines and their influence on mobilization efficacy and timing in patients with hematological malignancies.
    Szmigielska-Kaplon A; Krawczynska A; Czemerska M; Pluta A; Cebula-Obrzut B; Robak M; Grzybowska-Izydorczyk O; Szmigielska K; Robak T; Wierzbowska A
    J Clin Apher; 2015 Aug; 30(4):247-51. PubMed ID: 25352518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trafficking of CD34+ cells into the peripheral circulation during collection of peripheral blood stem cells by apheresis.
    Rowley SD; Yu J; Gooley T; Heimfeld S; Holmberg L; Maloney D; Bensinger WI
    Bone Marrow Transplant; 2001 Oct; 28(7):649-56. PubMed ID: 11704787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of hematopoietic stem cells mobilization in patients with multiple sclerosis.
    Kyrcz-Krzemień S; Helbig G; Torba K; Koclęga A; Krawczyk-Kuliś M
    Hematology; 2016 Jan; 21(1):42-5. PubMed ID: 26330136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
    Vogel W; Kopp HG; Kanz L; Einsele H
    J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclophosphamide plus granulocyte-colony stimulating factor for hematopoietic stem cell mobilization in patients with multiple myeloma.
    Lin TL; Wang PN; Kuo MC; Hung YH; Chang H; Tang TC
    J Clin Apher; 2016 Oct; 31(5):423-8. PubMed ID: 26340986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vinorelbine plus granulocyte colony-stimulation factor for CD34+ hematopoietic progenitor cell mobilization in patients with multiple myeloma.
    Samaras P; Pfrommer S; Seifert B; Petrausch U; Mischo A; Schmidt A; Schanz U; Nair G; Bargetzi M; Taverna C; Stupp R; Stenner-Liewen F; Renner C
    Biol Blood Marrow Transplant; 2015 Jan; 21(1):74-80. PubMed ID: 25278456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
    Tekgündüz E; Arat M; Göker H; Özdoğu H; Kaynar L; Çağırgan S; Erkurt MA; Vural F; Kiki İ; Altuntaş F; Demirkan F;
    Transfus Apher Sci; 2017 Dec; 56(6):845-849. PubMed ID: 29153306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of patients with multiple myeloma.
    Lemoli RM; Cavo M; Fortuna A
    J Hematother; 1996 Aug; 5(4):339-49. PubMed ID: 8877709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daily measurements of blood CD34+ cells after stem cell mobilization predict stem cell yield and posttransplant hematopoietic recovery.
    Remes K; Matinlauri I; Grenman S; Itälä M; Kauppila M; Pelliniemi TT; Salminen E; Vanharanta R; Rajamäki A
    J Hematother; 1997 Feb; 6(1):13-9. PubMed ID: 9112214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose etoposide plus granulocyte colony-stimulating factor as an effective chemomobilization regimen for autologous stem cell transplantation in patients with non-Hodgkin Lymphoma previously treated with CHOP-based chemotherapy: a study from the Consortium for Improving Survival of Lymphoma.
    Hyun SY; Cheong JW; Kim SJ; Min YH; Yang DH; Ahn JS; Lee WS; Ryoo HM; Do YR; Lee HS; Lee JH; Oh SY; Suh C; Yhim HY; Kim JS
    Biol Blood Marrow Transplant; 2014 Jan; 20(1):73-9. PubMed ID: 24141009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.